New Rules of Global Pharma: When Everything Changes at Once
Day 1 Global Pharma Stage
06/10/2026 10:30 - 11:00am
Contributors
Steffen Saltofte : CEO Zentiva, President Medicines for Europe - Zentiva / Medicines for Europe
The pharmaceutical industry is operating under fundamentally different rules than five years ago. Medicines are now treated as strategic national assets while still governed by cost-minimization economics. Manufacturing capacity has become selective rather than universal, with execution quality trumping price. Geopolitical tensions have transformed from background noise into active investment criteria, forcing companies to rebuild supply chains around resilience rather than efficiency.